Therefore, the depletion of ACE2 due to SARS-CoV-2 infection can contribute at least in part to the triad of hematological, pulmonary, and inflammatory outcomes of COVID-19 (Lanza et al., 2020; Verdecchia et al., 2020). Here, ACE2 is linked to COVID-19.